80 related articles for article (PubMed ID: 314085)
21. Killer cell immunoglobulin-like receptor expression delineates in situ Sézary syndrome lymphocytes.
Wechsler J; Bagot M; Nikolova M; Parolini S; Martin-Garcia N; Boumsell L; Moretta A; Bensussan A
J Pathol; 2003 Jan; 199(1):77-83. PubMed ID: 12474229
[TBL] [Abstract][Full Text] [Related]
22. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
[TBL] [Abstract][Full Text] [Related]
23. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
24. [Current pathogenetic aspects of Sézary syndrome and mycosis fungoides].
Dummer R; Willers J; Döbbeling U; Burg G
Hautarzt; 2001 Mar; 52(3):189-92. PubMed ID: 11284062
[TBL] [Abstract][Full Text] [Related]
25. Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation.
Roberts AA; Amano M; Felten C; Galvan M; Sulur G; Pinter-Brown L; Dobbeling U; Burg G; Said J; Baum LG
Mod Pathol; 2003 Jun; 16(6):543-51. PubMed ID: 12808059
[TBL] [Abstract][Full Text] [Related]
26. Exposure to chemicals, physical agents, and biologic agents in mycosis fungoides and the Sézary syndrome.
Fischmann AB; Bunn PA; Guccion JG; Matthews MJ; Minna JD
Cancer Treat Rep; 1979 Apr; 63(4):591-6. PubMed ID: 445514
[TBL] [Abstract][Full Text] [Related]
27. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
Rupniewska ZM
Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
[No Abstract] [Full Text] [Related]
28. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
[TBL] [Abstract][Full Text] [Related]
29. Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenotypic analysis suggesting the normal T-cell counterpart to the malignant mycosis fungoides/Sézary cell.
Payne CM; Spier CM; Grogan TM; Richter LC; Bjore CG; Cromey DW; Rangel CS
Am J Dermatopathol; 1988 Oct; 10(5):377-89. PubMed ID: 3265861
[TBL] [Abstract][Full Text] [Related]
30. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
Introcaso CE; Micaily B; Richardson SK; Junkins-Hopkins JM; Yoon JS; Kim EJ; Vittorio CC; Rook AH
J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
[TBL] [Abstract][Full Text] [Related]
31. Subpopulations of human T lymphocytes. IV. Quantitation and distribution in patients with mycosis fungoides and Sézary syndrome.
Gupta S; Safai B; Good RA
Cell Immunol; 1978 Aug; 39(1):18-26. PubMed ID: 308846
[No Abstract] [Full Text] [Related]
32. Epidermal Langerhans cells and prognosis of patients with mycosis fungoides and Sezary syndrome.
Meissner K; Löning T; Rehpenning W
In Vivo; 1993; 7(3):277-80. PubMed ID: 8357970
[TBL] [Abstract][Full Text] [Related]
33. Functionally distinct subpopulations of human T lymphocytes--a review.
Gupta S
Clin Bull; 1978; 8(3):100-6. PubMed ID: 311716
[No Abstract] [Full Text] [Related]
34. [Morphocytochemical characteristics of Sézary cells in the erythrodermic form of mycosis fungoides and Sézary syndrome].
Kozinets GI; Skripkin IuK; Lezvinskaia EM; Dul'tsina SM; Diagileva OA
Sov Med; 1986; (4):43-7. PubMed ID: 2940703
[No Abstract] [Full Text] [Related]
35. Sezary syndrome. I. Specific skin-directed migration of peripheral blood lymphocytes.
Laroche L; Papiernik M; Bach JF
J Immunol; 1983 May; 130(5):2467-70. PubMed ID: 6601151
[TBL] [Abstract][Full Text] [Related]
36. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
37. [Immunological characterization of malignant epidermotropic lymphoma cells in cutaneous infiltrates (author's transl)].
Thivolet J; Souteyrand P; Alario A; Schmitt D; Perrot H
Dermatologica; 1978; 157(6):357-64. PubMed ID: 363474
[TBL] [Abstract][Full Text] [Related]
38. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
Buechner SA; Winkelmann RK; Banks PM
Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
[TBL] [Abstract][Full Text] [Related]
39. [Sezary syndrome with serum monoclonal immunoglobulin. Absence of detectable shared idiotype between the monoclonal immunoglobulin and membrane structures of the Sezary cells (author's transl)].
Preud'homme JL; Sohier J; Danon F
Nouv Presse Med; 1980 Mar; 9(17):1215-7. PubMed ID: 7005868
[TBL] [Abstract][Full Text] [Related]
40. Sézary cells in ascitic fluid.
Vernon SE; Rosenthal DL
Acta Cytol; 1979; 23(5):408-11. PubMed ID: 316632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
